US · Healthcare

Wesana Health Holdings Inc (WSNAF)

Biotechnology

Wesana Health Holdings Inc (WSNAF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for WSNAF

P/E ratio

25.00

Wesana Health Holdings Inc (WSNAF) — FAQ

What is WSNAF's P/E ratio?

The price-to-earnings (P/E) ratio for Wesana Health Holdings Inc (WSNAF) is 25.00 (data as of 2026-05-23).

Does Wesana Health Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Wesana Health Holdings Inc (WSNAF). Check the MyAverix Finance app for the latest dividend data.

What sector is Wesana Health Holdings Inc in?

Wesana Health Holdings Inc (WSNAF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is WSNAF listed on?

WSNAF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)